Universität Münster
Welcome,         Profile    Billing    Logout  
 8 Trials 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eter, Nicole
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

Active, not recruiting
4
313
Europe, US
Teprotumumab, TEPEZZA, Placebo, Saline Solution
Amgen
Thyroid Eye Disease
04/26
04/26
SALUS, NCT04698876: Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation

Completed
N/A
267
Europe
Self-tonometry by means of ICareHOME, Intraocular measurement by means of rebound tonometry or Goldmann applanation tonometry, Blood pressure
University Hospital Muenster, Federal Joint Committee, Bielefeld University, Fraunhofer Institute for Applied Information Technology FIT, KVWL, BARMER, DAK Gesundheit, IKK, AOK PLUS
Glaucoma, Intraocular Pressure, Patient Empowerment, Telemedicine
10/23
11/23
Trebicka, Jonel
PRECIOSA, NCT03451292 / 2016-001789-28: Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites

Completed
3
410
Europe, Canada, US, RoW
Albutein 20% Injectable Solution, Standard medical treatment
Grifols Therapeutics LLC, Instituto Grifols, S.A.
Decompensated Cirrhosis and Ascites
05/24
05/24
NCT04950127 / 2021-000007-21: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

Active, not recruiting
3
238
Europe, Canada, Japan, US, RoW
Linerixibat, Placebo
GlaxoSmithKline
Pruritus
10/24
01/25
APACHE, NCT03702920 / 2016-001787-10: Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%

Recruiting
3
380
Europe, US
SMT + PE-A 5%, Albutein 5%, Standard Medical Treatment, SMT
Grifols Therapeutics LLC, Instituto Grifols, S.A.
Acute-On-Chronic Liver Failure
10/26
10/26
LLSAT, NCT04167358 / 2019-003158-10: Linerixibat Long-term Safety, and Tolerability Study

Recruiting
3
251
Europe, Canada, Japan, US, RoW
Linerixibat
GlaxoSmithKline, GlaxoSmithKline LLC, GlaxoSmithKline Research & Development Limited
Cholestasis
02/27
02/27
NCT05661331: VIATORR Device Registry

Recruiting
N/A
196
Europe
Transjugular intrahepatic portosystemic shunt, TIPS
W.L.Gore & Associates
Chronic Liver Disease
01/25
01/28

Download Options